31 January 2018 - At least £140 million is expected to be released into the NHS over the next five years from price discounts negotiated for medicines commissioned via the new Cancer Drugs Fund.

NHS England says it has secured discounts on eight treatments previously funded via the old CDF, which will generate additional savings for the NHS.

Since the new CDF in was rolled out in July 2016, nearly 15,700 patients have benefited from the 52 drugs treating 81 different types of cancer, of which around 5,000 received treatment sooner than they would have under old system.

Read Pharma Times article